DIOL Triterpenes Block Profibrotic Effects of Angiotensin II and Protect from Cardiac Hypertrophy-Reference-Cited by-同舟云学术

DIOL Triterpenes Block Profibrotic Effects of Angiotensin II and Protect from Cardiac Hypertrophy

Published:2012-07-23 Issue:7 Volume:7 Page:e41545
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Martín Ruben,Miana Maria,Jurado-López Raquel,Martínez-Martínez Ernesto,Gómez-Hurtado Nieves,Delgado Carmen,Visitación Bartolomé Maria,San Román José Alberto,Cordova Claudia,Lahera Vicente,Nieto Maria Luisa,Cachofeiro Victoria

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Dynamic interactions between myocytes, fibroblasts, and extracellular matrix.;L Banerjee;Ann NY Acad Sci,2006

2. Cardiac cellular heterogeneity and remodeling.;P Kohl;Cardiovasc Res,2004

3. The cardiac fibroblasts: therapeutic target in myocardial remodeling and failure.;RD Brown;Annu Rev Pharmacol Toxicol,2005

4. Temporal differences in fibroblasts proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone.;SE Campbell;J Mol Cell Cardiol,1995

5. Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts.;KT Weber;J Hypertens,2004

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pentacyclic triterpenes, potential novel therapeutic approaches for cardiovascular diseases;Archives of Pharmacal Research;2024-07-24

2. Performance of Olive-Pomace Oils in Discontinuous and Continuous Frying. Comparative Behavior with Sunflower Oils and High-Oleic Sunflower Oils;Foods;2021-12-11

3. Stability of Bioactive Compounds in Olive-Pomace Oil at Frying Temperature and Incorporation into Fried Foods;Foods;2021-11-24

4. The Interplay of Mitochondrial Oxidative Stress and Endoplasmic Reticulum Stress in Cardiovascular Fibrosis in Obese Rats;Antioxidants;2021-08-11

5. Targeting peroxisome proliferator-activated receptors: A new strategy for the treatment of cardiac fibrosis;Pharmacology & Therapeutics;2021-03